Last reviewed · How we verify

NCT03973255: WBV

Whole Body Vibration In Vestibular Rehabilitation

Completed NA Last updated 14 June 2022
What this trial tests

NA trial testing Rehabilitation in Vestibular Disease in 90 participants. Completed in 31 March 2019.

Timeline
13 March 2018
Primary endpoint
31 January 2019
31 March 2019

Quick facts

Lead sponsorPamukkale University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment90
Start date13 March 2018
Primary completion31 January 2019
Estimated completion31 March 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Pamukkale University

Who can join

Adults 18 to 65, any sex, with Vestibular Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to compare the efficacy of home based vestibular rehabilitation program, posturographic biofeedback training and whole body vibration therapy on balance, fall risk, functional mobility, vertigo symptom severity and functions in patients with unilateral vestibular weakness.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Rehabilitation

Trials testing the same drug.

Other recruiting trials for Vestibular Disease

Currently open trials in the same condition.

Other Pamukkale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03973255.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing